TFE3‐rearranged renal cell carcinoma (TFE3‐RCC) represents an aggressive subtype of renal cancer characterized by a poor prognosis, yet lacking clearly defined diagnostic and therapeutic targets. This evidence concerns the gene TFE3 and hereditary clear cell renal cell carcinoma.